These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 31574071)

  • 61. Nonalcoholic Fatty Liver Disease and Fibrosis in Youth Taking Psychotropic Medications: Literature Review, Case Reports, and Management.
    Gracious BL; Bhatt R; Potter C
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):602-10. PubMed ID: 26447642
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
    Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?
    Afdhal NH
    JAMA; 2012 Aug; 308(6):608-16. PubMed ID: 22760235
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reducing the load: the evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation.
    Watt KD
    Liver Transpl; 2012 Nov; 18 Suppl 2():S52-8. PubMed ID: 22821716
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China).
    Fan JG; Wei L; Zhuang H;
    J Dig Dis; 2019 Apr; 20(4):163-173. PubMed ID: 30444584
    [No Abstract]   [Full Text] [Related]  

  • 66. Pathophysiology guided treatment of nonalcoholic steatohepatitis.
    Nguyen TA; Sanyal AJ
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):58-64. PubMed ID: 22320918
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Beaton MD
    Can J Gastroenterol; 2012 Jun; 26(6):353-7. PubMed ID: 22720278
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.
    Younossi ZM; Blissett D; Blissett R; Henry L; Stepanova M; Younossi Y; Racila A; Hunt S; Beckerman R
    Hepatology; 2016 Nov; 64(5):1577-1586. PubMed ID: 27543837
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): prevalence, therapeutic innovations, and stumbling blocks for clinical development.
    Alkhouri N
    Expert Opin Investig Drugs; 2020 Feb; 29(2):115-116. PubMed ID: 31971024
    [No Abstract]   [Full Text] [Related]  

  • 70. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Chow MD; Lee YH; Guo GL
    Mol Aspects Med; 2017 Aug; 56():34-44. PubMed ID: 28442273
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis.
    Stine JG; Shah NL; Argo CK; Pelletier SJ; Caldwell SH; Northup PG
    Liver Transpl; 2015 Aug; 21(8):1016-21. PubMed ID: 25845711
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.
    Sayiner M; Koenig A; Henry L; Younossi ZM
    Clin Liver Dis; 2016 May; 20(2):205-14. PubMed ID: 27063264
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.
    Nabi O; Lacombe K; Boursier J; Mathurin P; Zins M; Serfaty L
    Gastroenterology; 2020 Aug; 159(2):791-793.e2. PubMed ID: 32376412
    [No Abstract]   [Full Text] [Related]  

  • 74. Obese children with fatty liver: Between reality and disease mongering.
    Ranucci G; Spagnuolo MI; Iorio R
    World J Gastroenterol; 2017 Dec; 23(47):8277-8282. PubMed ID: 29307987
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
    López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
    Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma: A Growing Epidemic?
    Yopp AC; Choti MA
    Dig Dis; 2015 Sep; 33(5):642-7. PubMed ID: 26398208
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis.
    Diehl AM; Day C
    N Engl J Med; 2017 Nov; 377(21):2063-2072. PubMed ID: 29166236
    [No Abstract]   [Full Text] [Related]  

  • 79. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
    Afzali A; Berry K; Ioannou GN
    Liver Transpl; 2012 Jan; 18(1):29-37. PubMed ID: 21932374
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View.
    Lindenmeyer CC; McCullough AJ
    Clin Liver Dis; 2018 Feb; 22(1):11-21. PubMed ID: 29128051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.